Skip to content
Screener

NovoCure NVCR Cash Flow Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
-$10.44M+72.0%-$15.66M+61.0%-$71.14M-107%-$24.5M+62.8%-$37.27M-21.9%
$4.42M+20.6%$4.31M+25.1%$4.12M+24.0%$4.22M+35.9%$3.66M+49.0%
$17.48M-40.4%$17.01M-34.9%$63.01M+113%$19.82M-68.4%$29.32M-6.5%
$22.67M+10.2%$8.13M+151%-$13.52M+62.1%-$18M-422%$20.57M+98.3%
$6.92M+22.4%$6.92M+26.1%$5.15M-51.4%$4.9M-45.2%$5.66M-47.1%
-$23.24M-133%-$6.38M-118%$7.75M+220%$336.33M+1,614%$71.44M+601%
$0-100%$0—$0—$0—$99.98M—
$0—$0—$0—$560.95M—$0—
$3.64M-96.4%$4.55M+90.5%-$166K-103%-$559.49M-20,938%$100.52M+100,417%
$3.22M-98.3%$6.29M-72.3%-$6.07M+83.5%-$241.25M-944%$192.51M+827%
$15.75M+5.5%$1.22M+106%-$18.67M+59.7%-$22.9M-84.8%$14.92M+4,960%

FAQ

How much cash does NovoCure generate?
NovoCure (NVCR) generated -$722.0K in operating cash flow over the trailing twelve months.
What is NovoCure's free cash flow?
After $23.9M of capital expenditures, NovoCure's free cash flow was -$24.6M over the trailing twelve months, up 62.2% year over year.
Where does NovoCure's cash flow data come from?
Every line is extracted from NovoCure's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.